Advertisement

Potential Role of Human T-cell Leukemia/Lymphoma Viruses (HTLV) in Diseases Other Than Acute T-cell Leukemia/Lymphoma (ATL)

  • Teresa C. Gentile
  • Thomas P. Loughran
Part of the Infectious Agents and Pathogenesis book series (IAPA)

Keywords

Chronic Fatigue Syndrome Antithyroid Antibody Large Granular Lymphocyte Leukemia Infective Dermatitis 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Poiesz, B. J., Ruscetti, F. W., Gazdar, A. F., Bunn, P. A., Minna, J. D., and Gallo, R. C., 1980, Detection and isolation of type C retrovirus particles from fresh and cultured lymphocytes of a patient with cutaneous T-cell lymphoma, Proc. Natl. Acad. Sci. USA 77:7415–7419.PubMedCrossRefGoogle Scholar
  2. 2.
    Manns, A., and Blattner, W. A., 1991, The epidemiology of human T cell lymphotrophic virus type I and type II: Etiologic role in human disease, Transfusion 31:67–75.CrossRefPubMedGoogle Scholar
  3. 3.
    Kalyanaraman, V. S., Sarngadharan, M. G., and Robert-Guroff, M., 1982, A new subtype of human T cell leukemia virus (HTLV II) associated with a T cell variant of hairy cell leukemia, Science 218:571–573.PubMedCrossRefGoogle Scholar
  4. 4.
    Rosenblat, J. D., Golde, D. W., and Wachsman, W., 1986, A second isolate of HTLV II associated with atypical hairy cell leukemia, N. Engl. J. Med. 315:372–377.CrossRefGoogle Scholar
  5. 5.
    Rosenblatt, J. D., Gasson, J. C., and Glaspy, J., 1987, Relationship between human T cell leukemia virus II and atypical hairy cell leukemia: A serologic study of hairy cell leukemia patients, Leukemia 1:397–401.PubMedGoogle Scholar
  6. 6.
    Gessian, A., Barin, F., Vernant, J. C., Gout, O., Maurs, L., and Calender, A. de The G., 1985, Antibodies to human T-lymphotropic virus type-I in patients with tropical spastic paraparesis, Lancet 2:407–410.CrossRefGoogle Scholar
  7. 7.
    Osame, M., Usuku, R, Izumo, S., Ijichi, N., Amitani, H., Igata, A., Matsumoto, M., and Tara, M., 1986, HTLV-I associated myelopathy, a new clinical entity, Lancet 1:1031–1032.PubMedCrossRefGoogle Scholar
  8. 8.
    Kaplan, J. E., Osame, M., Kubota, H., Igata, A., Nishitani, H., Maeda, Y., Khabbaz, R. F., and Janssen, R. S., 1990, The risk of development of HTLV-I-associated myelopathy/tropic spastic paraparesis among persons infected with HTLV-I, J. Acquired Immune Defic. Syndr. 3:1096–1101.Google Scholar
  9. 9.
    Roman, G., 1987, Retrovirus-associated myelopathies, Arch. Neural. 44:659–663.Google Scholar
  10. 10.
    Manns, A., and Blattner, W. A., 1991, The epidemiology of the human T-cell lymphotropic virus type I and type II: Etiologic role in human diseases, Transfusion 31:67–75.CrossRefPubMedGoogle Scholar
  11. 11.
    Murphy, E. L., Wilks, R., Morgan, O. S., Hanchard, B., Cranston, B., Figueroa, J. P., Gibbs, W. N., Murphy, J., and Blattner, W. A., 1989, Modeling the risk of adult T-cell leukemia/lymphoma (ATLL) in persons infected with human T-lymphotropic virus type-I, Int. J. Cancer 43:250–253.PubMedCrossRefGoogle Scholar
  12. 12.
    Hjelle, B., Appenzeller, O., Mills, R., Alexander, S., Torrez-Martinez, N., Jahnke, R., and Ross, G., 1992, Chronic neurodegenerative disease associated with HTLV-II infection, Lancet 339:645–646.CrossRefPubMedGoogle Scholar
  13. 13.
    Harrington, W. J., Jr., Sheremata, W., Hjelle, B., Dube, D. K., Bradshaw, P., Foung, S. R, Snodgrass, S., Toedter, G., Cabral, L., and Poiesz, B., 1993, Spastic ataxia associated with human T-cell lymphotropic virus type II infection, Ann. Neural. 33:411–414.CrossRefGoogle Scholar
  14. 14.
    Sheremata, W. A., Harrington, W. J., Bradshaw, P. A., Foung, S. K., Raffanti, S. P., Berger, J. R., Snodgrass, S., Resnick, L., and Poiesz, B. J., 1993, Association of “(tropical) ataxic neuropathy” with HTLV-II, Virus Res. 29:71–77.CrossRefPubMedGoogle Scholar
  15. 15.
    Jacobson, S., Lehky, T., Nishimura, M., Robinson, S., McFarlin, D. E., and Dhib-Jalbut, S., 1993, Isolation of HTLV-II from a patient with chronic progressive neurological disease clinically indistinguishable from HTLV I. Associated myelopathy/trophic spastic paraparesis, Ann. Neural. 33:392–396.CrossRefGoogle Scholar
  16. 16.
    Murphy, E. L., Engstrom, J. W., Miller, R., Sacher, R. A., Busch, M. P., and Hollingsworth, C. G., 1993, HTLV-II associated myelopathy in 43-year-oldwoman, Lancet 341:757–758.PubMedCrossRefGoogle Scholar
  17. 17.
    Lehky, T. J., Flerlage, N., Katz, D., Houff, S., Hall, W. S., Ishii, R., Monekn, C., Dhib-Jalbut, S., McFarland, H. F., and Jacobsen, S., 1996, Human T-cell lymphotrophic virus type II-associated myelopathy: Clinical and immunologic profiles, Ann. Neural. 40:714–723.CrossRefGoogle Scholar
  18. 18.
    Berger, J. R., Svenningsson, A., Raffanti, S., and Resnick, L., 1991, Tropical spastic paraparesis-like illness occurring in a patient dually infected with HIV-1 and HTLV-II, Neurology 41:85–87.PubMedGoogle Scholar
  19. 19.
    Rosenblatt, J. D., Tomkins, P., Rosenthal, M., Kacena, A., Chan, G., Valerama, R., Harrington, W., Jr., Saxton, E., Diagne, A., and Zhao, J. Q., 1992, Progressive spastic myelopathy in a patient coinfected with HIV-1 and HTLV-II: Autoantibodies to the human homologue of rig in blood and cerebrospinal fluid, AIDS 6:1151–1158.PubMedCrossRefGoogle Scholar
  20. 20.
    Gessain, A., and Gout, O., 1992, Chronic myelopathy associated with human T-lymphctropic virus type-1 (HTLV-l), Ann. Intern. Med. 117:933–946.PubMedGoogle Scholar
  21. 21.
    Douen, A. G., Pringle, C. E., and Guberman, A., 1997, Human T-cell lymphotropic virus type 1 myositis, peripheral neuropathy, and cerebral white matter lesions in the absence of spastic paraparesis, Arch. Neural. 54:896–900.Google Scholar
  22. 22.
    Zehender, G., DeMaddalena, C., Osio, M., Cavalli, B., Parravicini, C., Moroni, M., and Galli, M., 1995, High prevalence of human T-cell lymphotropic virus type II infection in patients affected by immunodeficiency virus type 1-associated predominantly sensory polyneuropathy, J. Infect. Dis. 172:1595–1598.PubMedGoogle Scholar
  23. 23.
    Verma, A., and Berger, J., 1995, Myasthenia gravis associated with dural infection of HIV and HTLV-I, Muscle Nerve 18:1355–1356.PubMedGoogle Scholar
  24. 24.
    Fukui, I., Sugita, R, Ichikawa, H., Negishi, A., Kasai, H., and Tsukagoshi, H., 1994, Human T lymphotropic virus type I associated myelopathy and myasthenia gravis: A possible association? Eur.Neural. 34:158–161.CrossRefGoogle Scholar
  25. 25.
    Ijichi, T., Adachi, Y., Nishio, A., Kanaitsuka, T., Ohtomo, T., and Nakamura, M., 1995, Myasthenia gravis, acute transverse myelitis, and HTLV-I, J. Neurol. Sci.: 133:194–196.CrossRefPubMedGoogle Scholar
  26. 26.
    Garcia, F., Castillo, L. C., Larreategui, M., Roberts, B., Cedeno, V., Heneine, W., Blattner, W., Kaplan, J. E., and Levine, P. H., 1995, Relation between human T-lymphotropic virus type I and neurologic diseases in Panama: 1985–1990, J. Acquired Immune Defic. Syndr. Hum. Retrovirol.: 10:192–197.Google Scholar
  27. 27.
    Lisby, G., 1993, Search for an HTLV-I like retrovirus in patients with MS by enzymatic DNA amplification, Acta Neurol. Scand. 88:385–387.PubMedCrossRefGoogle Scholar
  28. 28.
    Bhagavati, S., Ehrlich, G., Kula, R., Kowk, S., Sninsky, J., Udani, V., and Poiesz, B. J., 1988, Detection of human T-cell lymphoma/leukemia virus Type-I DNA and antigen in spinal fluid and blood of patients with chronic progressive myelopathy, N. Engl. J. Med.: 318:1141–1147.PubMedCrossRefGoogle Scholar
  29. 29.
    Kaplan, J. E., and Khabbaz, R. F., 1993, The epidemiology of human T-lymphotropic virus types I and II, Rev. Med. Virol.: 3:137–148.CrossRefGoogle Scholar
  30. 30.
    Bunn, P. A., Jr., Schechter, G. P., Jaffe, E., Blayney, D., Young, R. C., Matthews, M. J., Blatt-ner, W., Broder, S., Robert-Guroff, M., and Gallo, R. C., 1983, Clinical course of retrovirus-associated adult T-cell lymphoma in the United States, N. Engl. J. Med.: 309:257–264.PubMedCrossRefGoogle Scholar
  31. 31.
    Kawano, F., Yamaguchi, R, Nishimura, H., Tsuda, H., and Takatsuki, R, 1985, Variation in the clinical course of adult T-cell leukemia, Cancer: 55:851–856.PubMedCrossRefGoogle Scholar
  32. 32.
    Hall, W. W., Liu, C. R., Schneewind, O., Takahashi, H., Kaplan, M. H., Roupte, G., and Vahlne, A., 1991, Deleted HTLV-I provirus in blood and cutaneous lesions of patients with mycosis fungoides, Science: 253:317–320.PubMedCrossRefGoogle Scholar
  33. 33.
    Zucker-Franklin, D., Coutavas, E. E., Rush, M. G., and Zuozias, D. C., 1991, Detection of human T-lymphotropic virus-like particles in cultures of peripheral blood lymphocytes from patients with mycosis fungoids, Proc. Natl. Acad. Sci. USA: 88:7630–7634.PubMedCrossRefGoogle Scholar
  34. 34.
    Manca, N., Piacentini, E., Gelmi, M., Calzavara, P., Manganoni, M. A., Glukhov, A., Gar-giulo, F., DeFrancesco, M., Pirali, F., DePanfilis, G., and Turano, A., 1994, Persistence of human T-cell lymphotropic virus type I (HTLV-I) sequences in peripheral blood mono-nuclear cells from patients with mycosis fungoides, J. Exp. Med. 180:1973–1978.CrossRefPubMedGoogle Scholar
  35. 35.
    Zucker-Franklin, D., and Pancake, B. A., 1994, The role of human T-cell lymphotropic viruses (HTLV-I and II) in cutaneous T-cell lymphomas, Semin. Dermatol.: 13:160–165.PubMedGoogle Scholar
  36. 36.
    Fujiwara, Y., Abe, Y., Kuyama, M., Arata, Y., Yoshino, T., Akagi, T., and Miyoshi, R, 1990, CD8+ cutaneous T-cell lymphoma pagetoid epidermotropism and angiocentric and angiodestructive infiltration, Arch. Dermatol.: 126:801.CrossRefPubMedGoogle Scholar
  37. 37.
    Agnarsson, B. A., Vonderheid, E. C., and Kadin, M. E., 1990, Cutaneous T cell lymphoma suppressor/cytotoxic (CD8) phenotype: Identification of rapidly progressive and chronic subtypes, J. Am. Acad. Dermatol.: 22:569.PubMedGoogle Scholar
  38. 38.
    Loughran, T. P., Jr., Sherman, M. P., Ruscetti, F. W., Frey, S., Coyle, T., Montagna, R. A., Jones, B., Starkebaum, G., and Poiesz, B. J., 1994, Prototypical HTLV-I/II infection is rare in LGL leukemia, Leuk. Res.: 18:423–429.CrossRefPubMedGoogle Scholar
  39. 39.
    Loughran, T. P., Jr., Coyle, T., Sherman, M. P., Starkebaum, G., Ehrlich, G. D., Ruscetti, F. W., and Poiesz, B. J., 1992, Detection of human T-cell leukemia/lymphomavirus, type II, in a patient with large granular lymphocyte leukemia, Blood: 80:1116–1119.PubMedGoogle Scholar
  40. 40.
    Heneine, W., Chan, W., Lust, J., Sinha, S. D., Zaki, S. R., Khabbaz, R. F., and Kaplan, J. E., 1994, HTLV-II infection rare in patients with large granular lymphocyte leukemia, J. Acquired Immune Defic. Syndr.: 7:736–737.Google Scholar
  41. 41.
    Sohn, C. C., Blayne, D. W., Missett, J. L., Mathe, G., Flandrin, G., Moran, E. M., Jensen, F. C., Winberg, C. D., and Rappaport, H., 1986, Leukopenic chronic T-cell leukemia mimicking hairy-cell leukemia: Association with human retroviruses, Blood: 67:949–956.PubMedGoogle Scholar
  42. 42.
    Cervantes, J., Hussain, S., Jensen, F., and Schwartz, J. M., 1986, T-prolymphocytic leukemia associated with human T-cell lymphotropic virus II, Clin. Res. 34:454A [Abstract].Google Scholar
  43. 43.
    Kalyanaraman, V. S., Narayanan, P., Feorino, P., Ramsey, R. B., Palmer, E. L., Chorba, T., McDougal, S., Getchell, J. P., Holloway, B., and Harrison, A. K., 1985, Isolation and characterization of a human T-cell leukemia virus type II from a hemophilia-A patient with pancytopenia, EMBOJ.: 4:1455.Google Scholar
  44. 44.
    Ucar, A., Fernandez, H. F., Byrnes, J. J., Lian, E. C., and Harrington, W. J., Jr., 1994, Thrombotic microangiopathy and retroviral infections: A 13-year experience, Am. J. Hematol. 45:304–309.PubMedCrossRefGoogle Scholar
  45. 45.
    Dixon, A. C., Kwock, D. W., Nakamura, J. M., Yanagihara, E. T., Saiki, S. M., Bodner, A. J., and Alexander, S. S., 1989, Thrombotic thrombocytopenic purpura and human T-lymphotrophic virus, type I (HTLV-I), Ann. Intern. Med.: 110:93.PubMedGoogle Scholar
  46. 46.
    Levitt, L. J., Reyes, G. R., Moonka, D. K., Bensch, R, Miller, R. A., and Engleman, E. G., 1988, Human T cell leukemia virus-1-associated T-suppressor cell inhibition of erythropoiesis in a patient with pure red cell aplasia and chronic Ty-lymphoproliferative disease, J. Clin. Invest.: 81:538.PubMedCrossRefGoogle Scholar
  47. 47.
    Krieg, A. M., and Steinberg, A. D., 1990, Retroviruses and autoimmunity, J Autoimmun. 3:137–166.CrossRefPubMedGoogle Scholar
  48. 48.
    Nishioka, R, Marnyanna, I., Sato, R, Kitajima, I., Nakajima, Y., and Osane, M., 1989, Chronic inflammatory arthropathy associated with HTLV I, Lancet: 1:441.PubMedCrossRefGoogle Scholar
  49. 49.
    Kitajima, I., Yamamoto, R, Sato, K., Nakajima, Y., Nakajima, T., Maruyami, I., Osame, M., and Nishioka, K., 1991, Detection of human TCLVI proviral DNA and its gene expression in synovial cells in chronic inflammatory arthropathy, J. Clin. Invest.: 88:1315–1322.PubMedCrossRefGoogle Scholar
  50. 50.
    Guerin, B., Arfi, S., Numeric, P., Jean-Baptiste, G., LeParc, J. M., Smadja, D., and Grollier-Bois, L., 1995, Polyarthritis in HTLV-I-infected patients. A review of 17 cases, Rev. Rhum. Ed. Fr. 62:21–28.Google Scholar
  51. 51.
    Vernant, J. C., Buisson, G., Magdelein, J., DeThore, J., Jouannelle, A., Neisson-Vernant, C., and Monplaisir, N., 1988, T-lymphocyte alveolitis tropical spastic-paresis and Sjogren’s syndrome, Lancet: 1:177.PubMedCrossRefGoogle Scholar
  52. 52.
    Eguchi, K., Matsuoka, N., Ida, H., Nakashima, M., Sakai, M., Sakito, S., Kawakami, A., Terada, K., Shimada, H., and Kawabe, Y., 1992, Primary Sjogren’s syndrome with antibodies to HTLV-1: Clinical and laboratory features, Ann. Rheum. Dis.: 51:769–776.PubMedCrossRefGoogle Scholar
  53. 53.
    Terada, K, Katamine, S., Eguchi, K., Moriuchi, R., Kita, M., Shimada, H., Yamashita, I., Iwata, R, Tsuji, Y., Nagataki, S., and Miyamoto, T., 1994, Prevalence of serum and salivary antibodies to HTLV-1 in Sjogren’s syndrome, Lancet: 344:1115.CrossRefGoogle Scholar
  54. 54.
    Nakamura, H., Eguchi, R, Nakamura, T., Mizokami, A., Shirabe, S., Kawakami, A., Matsuoka, N., Migita, K., Kawabe, Y, and Nagataki, S., 1997, High prevalence of Sjogren’s syndrome in patients with HTLV-1 associated myelopathy, Ann. Rheum. Dis.: 56:167–172.PubMedCrossRefGoogle Scholar
  55. 55.
    Green, J. E., Hinrichs, S. H., Vogel, J., and Jay, G., 1989, Exocrinopathy resembling Sjogren’s syndrome in HTLV-1 tax transgenic mice, Nature: 341:72–74.CrossRefPubMedGoogle Scholar
  56. 56.
    Garry, R. F., Fermin, C. D., Hart, D. J., Alexander, S. S., Donehower, L. A., and Luc-Zhang, H., 1990, Detection of a human intracisternal A-type retroviral particle antigenically related to HIV, Science: 250:1127–1129.PubMedCrossRefGoogle Scholar
  57. 57.
    Yamano, S., Renard, J. N., Mizuno, F., Narita, Y., Uchida, Y., Higashiyama, H., Sakurai, H., and Saito, I., 1997, Retrovirus in salivary glands from patients with Sjogren’s syndrome, J. Clin. Pathol.: 50:223–230.PubMedCrossRefGoogle Scholar
  58. 58.
    Matsumoto, Y., Muramatsu, M. O., and Sato, R, 1993, Mixed connective tissue disease and Sjogren’s syndrome, accompanied by HTLV-1 infection, J. Intern. Med.: 32:261–264.CrossRefGoogle Scholar
  59. 59.
    Mine, H., Kawai, H., Yokoi, K, Akaike, M., and Saito, S., 1996, High frequencies of human T-lymphotropic virus type I (HTLV-I) infection and presence of HTLV-II proviral DNA in blood donors with anti-thyroid antibodies, J. Mol. Med. 74471–477.Google Scholar
  60. 60.
    Mizokami, T., Okamura, K., Ikenoue, H., Sato, K., Kuroda, T., Maeda, Y., and Fujishima, M., 1994, A high prevalence of human T-lymphotropic virus type I carriers in patients with antithyroid antibodies, Thyroid: 4:415–419.PubMedCrossRefGoogle Scholar
  61. 61.
    Yokoi, K., Kawai, H., Akaike, M., Mine, H., and Saito, S., 1995, Presence of human T-lymphotropic virus type 11-related genes in DNA of peripheral leukocytes from patients with autoimmune thyroid diseases, J. Med. Virol.: 45:392–398.PubMedCrossRefGoogle Scholar
  62. 62.
    Akamine, H., Takasu, N., Komiya, I., Ishikawa, K., Shinjyo, T., Nakachi, K., and Masuda, M., 1996, Association of HTLV-I with autoimmune thyroiditis in patients with adult T-cell leukemia (ATL) and in HTLV-I carriers, Clin. Endorinol.: 45:461–466.CrossRefGoogle Scholar
  63. 63.
    Kawai, H., Yokoi, K., Akaike, M., Kunishige, M., Abe, M., Tanouchi, Y., Mine, H., Mimura, Y., and Saito, S., 1995, Graves’ disease in HTLV-1 carriers, J. Mol. Med.: 73:85–88.CrossRefPubMedGoogle Scholar
  64. 64.
    Kawai, H., Mitsui, T., Yokoi, K., Akaike, M., Hirose, K., Hizawa, K., and Saito, S., 1996, Evidence of HTLV-1 in thyroid tissue in an HTLV-1 carrier with Hashimoto’s thyroiditis, J. Mol. Med.: 74:275–278.PubMedCrossRefGoogle Scholar
  65. 65.
    Yokoi, K., Kawai, H., Akaike, M., Mine, H., and Saito, S., 1995, Presence of human T-lymphotropic virus type 11-related genes in DNA of peripheral leukocytes from patients with autoimmune thyroid disease, J. Med. Virol.: 45:382–398.CrossRefGoogle Scholar
  66. 66.
    LaGrenade, L., 1994, HTLV-I, infective dermatitis, and tropical spastic paraparesis, Mol. Neurobiol.: 8:147–153.CrossRefGoogle Scholar
  67. 67.
    LaGrenade, L., Schwartz, R. A., and Janniger, C. K., 1996, Childhood dermatitis in the tropics: With special emphasis on infective dermatitis, a marker for infection with human T-cell leukemia virus-I, Cutis: 58:115–118.Google Scholar
  68. 68.
    Kaplan, M. H., Sadick, N. S., McNutt, N. S., Talmor, M., Coronesi, M., and Hall, W. W., 1993, Acquired ichthyosis in concomitant HIV-I and HTLV-II infection: A new association with intravenous drug abuse, J. Am. Acad. Dermatol.: 29:701–708.PubMedGoogle Scholar
  69. 69.
    Kaplan, M. H., Hall, W. W., Susin, M., Pahwa, S., Salahuddin, S. Z., Heilman, C., Fetten, J., Coronesi, M., Farber, B. F., and Smith, S., 1991, Syndrome of severe skin disease, eosinophilia, and dermatopathic lymphadenopathy in patients with HTLV-II complicating human immunodeficiency virus infection, Am. J. Med. 91:300–309.CrossRefPubMedGoogle Scholar
  70. 70.
    DeFreitas, E., Hilliard, B., Cheney, P. R., Bell, D. S., Kiggundu, E., Sankey, D., Wroblewska, Z., Palladino, M., Woodward, J. P., and Koprowski, H., 1991, Retroviral sequences related to human T-lymphotropic virus type II in patients with chronic fatigue immune dysfunction syndrome, Proc. Natl. Acad. Sci. USA: 88:2922–2926.PubMedCrossRefGoogle Scholar
  71. 71.
    Ejima, E., Rosenblatt, J. D., Ou, J., and Prager, D., 1995, Parathyroid hormone-related protein gene expression and human T-cell leukemia virus-I infection, Miner. Electrolyte Metab.: 21:143–147.PubMedGoogle Scholar
  72. 72.
    Ejima, E., Rosenblatt, J. D., Massari, M., Quan, E., Stephens, D., Rosen, C. A., and Prager, D., 1993, Cell-type-specific transactivation of the parathyroid hormone-related protein gene promoter by the human T-cell leukemia virus type I (HTLV-I) tax and HTLV-II tax proteins, Blood: 81:1017–1024.PubMedGoogle Scholar

Copyright information

© Kluwer Academic Publishers 2002

Authors and Affiliations

  • Teresa C. Gentile
    • 1
  • Thomas P. Loughran
    • 2
    • 3
  1. 1.Department of MedicineSUNY Health Sciences CenterSyracuse
  2. 2.Program Leader, Hematological Malignancies, H. Lee Moffitt Cancer Center and Research InstituteVeterans Administration HospitalTampa
  3. 3.Departments of Medicine and Microbiology/ImmunologyUniversity of South Florida College of MedicineTampa

Personalised recommendations